44 2033180199
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Journal of Neurology and Clinical Neuroscience

Sign up for email alert when new content gets added: Sign up

Medical device alternatives to restless legs syndrome (RLS) Dopaminergic Drugs

Author(s): Helly Simmons*

RLS (Restless Legs Syndrome) is a prevalent neurological condition that affects 2.5–15% of the Western population. Sleep loss impairs everyday function for one–third to one–half of RLS sufferers. Patients with RLS dread the start of each RLS attack because they are so unpleasant. The most generally established treatment for RLS is drugs that pass the blood–brain barrier. Ergot and non-ergot derived dopaminergic medications were proposed as therapies for RLS in the 1980s. However, reports of severe mid– and long–term complications following dopaminergic medication therapy of RLS began to emerge in the 1970s, including tartive dyskinesia as a result of widespread usage of antipsychotic medicines.

Google Scholar citation report
Citations : 500

Journal of Neurology and Clinical Neuroscience received 500 citations as per Google Scholar report

Journal of Neurology and Clinical Neuroscience peer review process verified at publons